Search Results
Apr 01, 2026, 20:05 ET INOVIO Announces Proposed Public Offering
biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting
More news about: INOVIO Pharmaceuticals, Inc.
Apr 01, 2026, 13:51 ET Midea predstavuje H-Pack na veľtrhu MCE 2026: významný krok vpred v oblasti cenovo dostupnej technológie a servisu kompaktných tepelných čerpadiel
proces zlúčením všetkých hydraulických komponentov do jedného kompaktného modulu. Vďaka tomu sa skracuje čas pripojenia z jedného celého pracovného dňa na približne jednu hodinu. Tento dizajn umožňuje spotrebiteľom začať s hybridným systémom a v budúcnosti prejsť na plne elektrický systém jednoduchou
More news about: Midea Residential Air Conditioning
Apr 01, 2026, 13:49 ET Synpulse benoemt terugkerend leider Patrick Becher als COO om Agentic Operating Model aan te sturen
praktische drijver van efficiëntie, kwaliteit en snelheid."Co-CEO Yves Roesti voegt eraan toe: "Patrick vertegenwoordigt de ideale mix van Synpulse-DNA en frisse blik. Naarmate we van 'ambachtelijk opschalen' en AI in zowel ons aanbod als onze interne manier van werken integreren, zal hij een centrale
More news about: Synpulse
Apr 01, 2026, 13:47 ET Synpulse ernennt zurückkehrende Führungskraft Patrick Becher zum Betriebsleiter, um das agentische Betriebsmodell voranzutreiben
Qualität und Geschwindigkeit nutzen können."Mitgeschäftsführer Yves Roesti fügt hinzu: „Patrick verkörpert die ideale Mischung aus der Synpulse-DNA und einer neuen Perspektive. Während wir den Schritt von ‚Handwerk zu Skalierung' vollziehen und KI sowohl in unser Angebot als auch in unsere internen
More news about: Synpulse
Apr 01, 2026, 13:09 ET Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection
stages. The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique "fingerprint" of cancer. The Galleri test has not been cleared or approved by the Food and Drug Administration.
More news about: Superpower
Apr 01, 2026, 11:00 ET Synpulse Appoints Returning Leader Patrick Becher as COO to Drive Agentic Operating Model
and harness AI as a practical driver of efficiency, quality and speed."Co-CEO Yves Roesti adds: "Patrick represents the ideal mix of Synpulse DNA and fresh perspective. As we move from 'craft to scale' and embed AI into both our offerings and our internal ways of working, he will play a central
More news about: Synpulse
Apr 01, 2026, 10:39 ET Atlantic Ultraviolet Corporation® Achieves A+ Accreditation with the Better Business Bureau®
plants, manufacturing facilities, food and beverage processing, and the technology sector. Germicidal UV lamps produce wavelengths that are lethal to the DNA of bacteria, viruses, and other microorganisms in water, in air, and on surfaces. UV-C technology is effective, economical, safe (chemical-free), quick,
More news about: Atlantic Ultraviolet Corporation
Apr 01, 2026, 10:29 ET INOVIO to Participate in Upcoming Scientific Conference
Therapeutics: DNA-Encoded Protein (DPROT) Technology Demonstrates in vivo Production of Functional FVIII in Mouse ModelDate: Wednesday, April 22Time: 9:45 AM MYTPoster Presentation: FVIII Expression Via Non-viral Vector DNA Medicine
More news about: INOVIO Pharmaceuticals, Inc.
Apr 01, 2026, 09:15 ET Bain & Company appoints Hernan Saenz to lead its Global Strategy & Transformation practice
François Faelli, global head of capabilities at Bain & Company, said: "Transformation has been part of our Bain DNA for more than 50 years. It's at the core of what we do. Under Hernan's leadership, our Strategy & Transformation practice will harness the full range
More news about: Bain & Company
Apr 01, 2026, 09:01 ET Fairmont Hotels & Resorts Debuts New Immersive "Special Happens..." Experiences Across Its Global Portfolio
Kaplan, Chief Brand Officer, Fairmont Hotels & Resorts said, "Delivering remarkable experiences is fundamental to Fairmont Hotels & Resorts' DNA. With these brand new 'Special Happens...' experiences, we're not just continuing this legacy, we're actively bringing the essence of Fairmont to life
More news about: Fairmont Hotels & Resorts
Apr 01, 2026, 09:00 ET Thatch Welcomes Venteur Customers to Advance Shared Health Benefits Mission
affordable, personalized, and built around people," said Stacy Edgar, CEO and Co-Founder of Venteur. "In Thatch, we've found a partner that shares that core DNA. This moment is a force-multiplier for our mission to build a healthcare system that finally sees the individual behind the coverage. Our priority throughout
More news about: Thatch
Apr 01, 2026, 05:00 ET Synpulse Appoints Returning Leader Patrick Becher as COO to Drive Agentic Operating Model
and harness AI as a practical driver of efficiency, quality and speed."Co-CEO Yves Roesti adds: "Patrick represents the ideal mix of Synpulse DNA and fresh perspective. As we move from 'craft to scale' and embed AI into both our offerings and our internal ways of working, he will play a central
More news about: Synpulse
Apr 01, 2026, 01:53 ET 鎧應科技 2026 Touch Taiwan 重磅登場 AI 內容生成 × 電子紙永續 × 台灣自主資安，重新定義智慧顯示未來
AI 爆發、永續浪潮席捲全球，數位看板已成企業最前線的溝通中樞，同時也面臨日益嚴峻的資安挑戰。鎧應科技以 20 年台灣自主研發實力，攜三大突破性方案，進駐 2026 Touch Taiwan（4 月 8–10 日，南港展覽館 1 館 4 樓 N1019）。 資安：鎧應的核心 DNA 100% 台灣研發，從底層 OS 到應用軟體全自主掌控，無外包黑盒子。專屬 Linux 架構封鎖惡意入侵，內建加密傳輸、防火牆、IP 存取控制，CMS 伺服器本地化部署確保數據主權。政府、醫療、教育等高資安需求場域已廣泛採用，信賴有據。AI 驅動內容創作零門檻 全新
More news about: 鎧應科技股份有限公司
Mar 31, 2026, 20:49 ET The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
milestones in the sector right now. Prime Medicine (NASDAQ: PRME) is developing prime editing — a next-generation gene editing platform that rewrites DNA without cutting both strands, reducing the off-target risks that have haunted earlier CRISPR approaches. The technology promises more precise manufacturing
More news about: USA News Group
Mar 31, 2026, 16:01 ET Co-Diagnostics Reports Full Year 2025 Financial Results
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Mar 31, 2026, 11:11 ET New FDA Plausible Mechanism Framework Spurs Development of Personalized In Vivo Prime Editing Platform for Urea Cycle Disorders
In preclinical studies, giving the AAV first and the LNP two weeks later corrected about 30 to 40% of the copies of the genetic variant in the liver DNA – much higher than the roughly 10% correction researchers typically consider necessary for a clinical benefit for UCDs."This two‑part approach
More news about: Children's Hospital of Philadelphia
Mar 31, 2026, 11:00 ET Alltrna Announces Approval to Initiate First-in-Human Clinical Trial of AP003, the First tRNA Therapeutic to Enter Clinical Trials
nonsense mutation in the affected gene. The Arg-TGA variant occurs when a single base of the arginine-encoding codons, CGA and AGA, mutates to UGA (TGA in DNA), a termination codon for which there is no corresponding amino acid. AP003 is designed to read through the premature termination codon to reintroduce
More news about: Alltrna
Mar 31, 2026, 09:49 ET Veteran Tech Executive Scott Van Vliet Joins Xoriant's Board
Scott Van Vliet, said, "What excites me about Xoriant is the rare combination of deep engineering DNA, a clear Applied Intelligence vision, and the agility to move faster than companies many times its size. The next frontier of enterprise AI isn't just
More news about: Xoriant
Mar 31, 2026, 09:07 ET 2026 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-LEADING SCIENTISTS FOR BREAKTHROUGH DISCOVERIES ADVANCING HUMAN HEALTH
replication as a form of "chemical immunity." Her work also shows that bacterial immunity is shaped by genes carried on mobile pieces of DNA, including viral DNA left behind in bacterial genomes. These dormant viral elements can actively protect their hosts by detecting invading viruses and triggering
More news about: Gairdner Foundation
Mar 31, 2026, 08:49 ET New Analysis Highlights Role of Antioxidants in Male Fertility
stress) can negatively impact male health. Specifically, the study reported that this "can trigger detrimental OS reactions, including lipid peroxidation, DNA damage and impaired sperm function, contributing to male infertility."This connection between OS and male fertility is a major focus of California
More news about: California Greens
Mar 31, 2026, 08:43 ET California Greens Highlights Double-Header Women's Awareness in March
oxidative stress, protect oocytes, and support reproductive health.Methylated Folate (L-Methylfolate): A bioactive form of folate that supports DNA synthesis, healthy cell division, and improves fertility outcomes."Reproductive health and fertility are important components of women's
More news about: California Greens
Mar 31, 2026, 08:17 ET GomSpace Secures 815.000 EUR (8.8 MSEK) Authorization to Proceed from Unseenlabs for Next Constellation Tranche
of the program, we help our customers de-risk their roadmap and meet ambitious deployment timelines. This approach is deeply embedded in GomSpace's DNA."The ATP is part of the broader program framework between Unseenlabs and GomSpace and reflects the ongoing demand for resilient, high-performance
More news about: GomSpace A/S
Mar 31, 2026, 06:06 ET iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience
More news about: iHuman Inc.
Mar 31, 2026, 06:00 ET Herbie Hancock Institute of Jazz vyhlasuje Medzinárodnú jazzovú vokálnu súťaž 2026 v Paríži v spolupráci s Louis Vuitton Foundation
vedu a kultúru so sídlom v Paríži – je inštitút vedúcou neziskovou organizáciou zodpovednou za plánovanie, propagáciu a organizovanie Medzinárodného dňa džezu, globálnej oslavy džezu a jeho úlohy v kultúrnej diplomacii, ktorý sa každoročne oslavuje 30. apríla vo viac ako 190 krajinách.Viac informácií
More news about: Herbie Hancock Institute of Jazz
Mar 30, 2026, 19:01 ET Material Intelligence in Motion: Engineering the Future of Adaptive Apparel at Functional Fabric Fair Spring 2026
from day one.Smart Textiles in ActionMakalot's WIIM platform integrates multi-patented technology directly into the material DNA. By prioritizing safety and wearability, the platform expands the boundaries of what a garment can do. From physiological-signal sensing and integrated
More news about: MAKALOT industrial co., ltd.